Discover the Sun Pharma Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Sun Pharma will be responsible for pursuing regulatory approvals in licensed territories where approval has not yet been ...

Moody's and S&P Global Ratings assigned investment-grade ratings to Sun Pharma after factoring in its $11.75 billion acquisition of Organon. Bernstein said the ratings validate its view that combined ...

Pharma sector stocks such as Sun Pharma, Dr Reddy’s, Cipla, Biocon, Shilpa Medicare, Zydus Life and Hester Bio are in focus ...

Sun Pharmaએ અમેરિકન સરકાર સાથે કરાર કર્યો છે, જેના હેઠળ US Medicaid Programme માટે દવાઓ MFN Pricing હેઠળ ઓછી કિંમતે સપ્લાય કરવામાં આવશે. ભવિષ્યમાં લોન્ચ થનારી Innovative Medicines પણ આ કરારમાં સામેલ થ ...

Geojit Financial Services is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target ...

Geojit Investments recommends buying Sun Pharma with a target price of ₹2,070, highlighting strong growth and innovation.

NSE: With this market debut, the stock has entered the league of top 10 Indian firms listed in terms of market cap on BSE.

Bernstein and HSBC retained their bullish ratings on Sun Pharma. Analysts highlighted the two-year tariff relief secured under the agreement and saw manageable financial implications from the pricing ...

Varmora Granito Share Price: Varmora Granito shares got listed on September 29 at an issue price of Rs 148, following 1.60x ...

Sun Pharma has agreed to offer 'Most Favoured Nation' pricing to US Medicaid programmes in exchange for a delay in Section 232 tariffs on its innovative medicines. The agreement shows how pricing, ...

NSE dominates Indian exchanges with a near-monopoly in cash equities and future trading volumes. In the cash segment, it has ...